OSCR
Oscar Health, Inc.
Price Chart
Latest Quote
$28.54
+0.14 (+0.49%)
Current Price
| Previous Close | $28.40 |
| Open | $28.32 |
| Day High | $29.52 |
| Day Low | $28.38 |
| Volume | 5,159,373 |
Stock Information
| Shares Outstanding | 265.90M |
| Total Debt | $482.24M |
| Cash Equivalents | $6.80B |
| Revenue | $13.30B |
| Net Income | $-39.43M |
| Sector | Healthcare |
| Industry | Healthcare Plans |
| Market Cap | $8.60B |
| EPS (TTM) | $-0.54 |
| Exchange | NYQ |
đ Comprehensive Analysis
Company Data
| Enterprise Value | $2.28B |
| Sales | $13.30B |
| Income | $-39.43M |
| Book/sh | $5.57 |
| Cash/sh | $25.57 |
| Employees | 2K |
Financial Ratios
| Quick Ratio | 1.07 |
| Current Ratio | 1.09 |
| Debt/Eq | 28.93 |
| EPS Growth TTM | 146.70% |
Returns & Margins
| ROA | 0.09% |
| ROE | -2.62% |
| Gross Margin | 17.39% |
| Operating Margin | 15.15% |
| Profit Margin | -0.30% |
Ownership
| Insider Ownership | 5.38% |
| Institutional Ownership | 67.57% |
| Insider & Institutional transactions data not available | |
Valuation Ratios
| Forward P/E | 19.54 |
| P/S | 0.65 |
| P/B | 5.13 |
Analyst Data
| Recommendation | hold |
| Target Price | $22.60 |
Technical Indicators
| SMA20 | $25.32 |
| SMA50 | $21.61 |
| SMA200 | $17.42 |
| RSI | 70.05 |
| ATR | 1.9120 |
| Shares Float | 246.79M |
| Short Float | 7.34% |
| Short Ratio | 2.13 |
| Volatility | 2.39 |
| Rel Volume | 0.73 |
Performance History
| Week | +0.99% |
| Month | +21.86% |
| Quarter | +125.97% |
| 6 Months | +85.45% |
| YTD | +90.65% |
| Year | +52.05% |
| 3 Years | +212.25% |
| 5 Years | +14.16% |
| 10 Years | -17.99% |
Stock Score:
â Premium
Based on debt, profitability, growth, and cash flow metrics
â Premium Feature
Sign up for free to view detailed scoring breakdown â premium is free during our trial period!
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-06-22 | $28.54 | 5,190,400 |
| 2026-06-18 | $28.40 | 6,781,300 |
| 2026-06-17 | $28.27 | 5,062,500 |
| 2026-06-16 | $28.56 | 4,347,100 |
| 2026-06-15 | $29.14 | 6,243,400 |
| 2026-06-12 | $28.26 | 5,815,000 |
| 2026-06-11 | $28.91 | 6,995,500 |
| 2026-06-10 | $27.85 | 8,645,400 |
| 2026-06-09 | $27.22 | 9,132,000 |
| 2026-06-08 | $27.39 | 14,958,900 |
| 2026-06-05 | $24.51 | 9,386,000 |
| 2026-06-04 | $23.60 | 10,721,400 |
| 2026-06-03 | $20.50 | 6,681,200 |
| 2026-06-02 | $21.14 | 8,536,600 |
| 2026-06-01 | $22.97 | 7,585,600 |
| 2026-05-29 | $22.23 | 5,480,200 |
| 2026-05-28 | $22.33 | 4,706,200 |
| 2026-05-27 | $21.99 | 5,394,300 |
| 2026-05-26 | $21.89 | 5,840,100 |
About Oscar Health, Inc.
Oscar Health, Inc. operates as a healthcare technology company in the United States. The company offers health plans to individuals, families, employees, and small group markets. It also provides +Oscar platform that power others throughout the healthcare system; Campaign Builder platform, an engagement and recommendation platform for providers and payors; and reinsurance products. In addition, the company offers brokerage services and enrollment platform for brokers and consumers to shop, buy, and enroll in medical and supplemental health products. The company was formerly known as Mulberry Health Inc. and changed its name to Oscar Health, Inc. in January 2021. Oscar Health, Inc. was incorporated in 2012 and is headquartered in New York, New York.
đ° Latest News
1 Cash-Heavy Stock with Impressive Fundamentals and 2 Facing Headwinds
StockStory âĸ 2026-06-16T12:01:04Z
This Little-Known Healthcare Stock Is Up 90% This Year, and the Party Might Just Be Getting Started
Motley Fool âĸ 2026-06-14T18:20:00Z
Oscar Health, Inc. (OSCR) Stock Declines While Market Improves: Some Information for Investors
Zacks âĸ 2026-06-12T22:00:03Z
Oscar Health (OSCR) Stock Valuation After Conference Rally And Reaffirmed 2026 Guidance
Simply Wall St. âĸ 2026-06-12T07:12:06Z
Is Oscar Health, Inc. (OSCR) A Good Stock To Buy Now?
Insider Monkey âĸ 2026-06-11T20:30:40Z
Why Did AMAT, AMPG, OSCR Stocks Surge To 52-Week Highs Today?
Stocktwits âĸ 2026-06-11T03:10:14Z
Barclays Just Upgraded Oscar Health Stock. Here's Why.
Barchart âĸ 2026-06-10T20:26:52Z
How AI Will Change the Job Marketâand Boost These Health Insurance Stocks
Barrons.com âĸ 2026-06-10T17:50:00Z
Nike downgraded, Oscar Health upgraded: Wall Street's top analyst calls
The Fly âĸ 2026-06-10T13:42:21Z
Why Did AAPL, OSCR, LLY Stocks Hit 52-Week Highs Today?
Stocktwits âĸ 2026-06-09T03:08:18Z
Period:
Loading...
Income Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Revenue | ||||
| Total Revenue | $11,701,427,000 | $9,177,941,000 | $5,862,869,000 | $4,125,584,000 |
| Operating Revenue | $11,701,427,000 | $9,177,941,000 | $5,862,869,000 | $4,125,584,000 |
| Expenses | ||||
| Interest Expense | $17,601,000 | $23,734,000 | $24,603,000 | $22,623,000 |
| Total Expenses | $12,138,724,000 | $9,144,515,000 | $6,130,169,000 | $4,735,659,000 |
| Other Income Expense | $28,593,000 | $20,576,000 | - | $3,880,000 |
| Net Non Operating Interest Income Expense | $-17,601,000 | $-23,734,000 | $-24,603,000 | $-22,623,000 |
| Interest Expense Non Operating | $17,601,000 | $23,734,000 | $24,603,000 | $22,623,000 |
| Other Operating Expenses | $23,339,000 | $105,000 | $7,082,000 | $-2,415,000 |
| General And Administrative Expense | $2,049,867,000 | $1,755,942,000 | $1,424,763,000 | $1,419,370,000 |
| Loss Adjustment Expense | $10,019,025,000 | $7,332,589,000 | $4,642,024,000 | $3,280,798,000 |
| Income & Earnings | ||||
| Net Income From Continuing Operation Net Minority Interest | $-443,151,000 | $25,432,000 | $-270,728,000 | $-606,275,000 |
| Net Interest Income | $-17,601,000 | $-23,734,000 | $-24,603,000 | $-22,623,000 |
| Normalized Income | $-443,151,000 | $25,432,000 | $-270,728,000 | $-606,275,000 |
| Net Income From Continuing And Discontinued Operation | $-443,151,000 | $25,432,000 | $-270,728,000 | $-606,275,000 |
| Net Income Common Stockholders | $-443,151,000 | $25,432,000 | $-270,728,000 | $-606,275,000 |
| Net Income | $-443,151,000 | $25,432,000 | $-270,728,000 | $-606,275,000 |
| Net Income Including Noncontrolling Interests | $-442,903,000 | $26,121,000 | $-270,594,000 | $-609,552,000 |
| Net Income Continuous Operations | $-442,903,000 | $26,121,000 | $-270,594,000 | $-609,552,000 |
| Pretax Income | $-437,297,000 | $33,426,000 | $-267,300,000 | $-610,075,000 |
| Depreciation And Amortization In Income Statement | $28,892,000 | $32,145,000 | $30,694,000 | $15,283,000 |
| Special Income Charges | - | - | $0 | $0 |
| Interest Income | - | - | - | $31,306,000 |
| Per Share | ||||
| Diluted EPS | $-1.69 | $0.10 | $-1.22 | $-2.85 |
| Basic EPS | $-1.69 | $0.10 | $-1.22 | $-2.85 |
| Other | ||||
| Tax Effect Of Unusual Items | $0 | $0 | $0 | $0 |
| Tax Rate For Calcs | $0 | $0 | $0 | $0 |
| Reconciled Depreciation | $28,892,000 | $32,145,000 | $30,694,000 | $15,283,000 |
| EBIT | $-419,696,000 | $57,160,000 | $-242,697,000 | $-587,452,000 |
| Diluted Average Shares | $262,388,000 | $265,853,000 | $221,655,493 | $212,474,615 |
| Basic Average Shares | $262,388,000 | $265,853,000 | $221,655,493 | $212,474,615 |
| Diluted NI Availto Com Stockholders | $-443,151,000 | $25,432,000 | $-270,728,000 | $-606,275,000 |
| Minority Interests | $-248,000 | $-689,000 | $-134,000 | $3,277,000 |
| Tax Provision | $5,606,000 | $7,305,000 | $3,294,000 | $-523,000 |
| Selling General And Administration | $2,049,867,000 | $1,755,942,000 | $1,424,763,000 | $1,419,370,000 |
| Other Gand A | $2,049,867,000 | $1,755,942,000 | $1,424,763,000 | $1,419,370,000 |
| Net Policyholder Benefits And Claims | $10,019,025,000 | $7,332,589,000 | $4,642,024,000 | $3,280,798,000 |
| Policyholder Benefits Gross | $10,163,176,000 | $7,491,721,000 | $4,686,760,000 | $4,571,147,000 |
| Policyholder Benefits Ceded | $144,151,000 | $159,132,000 | $44,736,000 | $1,290,349,000 |
| Total Unusual Items | - | - | $0 | $0 |
| Total Unusual Items Excluding Goodwill | - | - | $0 | $0 |
| Other Special Charges | - | - | - | - |
Fetched: 2026-06-22
Balance Sheet (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Assets | ||||
| Net Tangible Assets | $977,648,000 | $1,013,586,000 | $803,967,000 | $890,384,000 |
| Total Assets | $6,325,411,000 | $4,840,496,000 | $3,601,480,000 | $4,526,601,000 |
| Receivables | $598,461,000 | $672,207,000 | $494,388,000 | $1,159,223,000 |
| Other Receivables | $56,066,000 | $64,779,000 | $51,925,000 | $49,861,000 |
| Accounts Receivable | $542,395,000 | $607,428,000 | $442,463,000 | $1,109,362,000 |
| Cash Cash Equivalents And Short Term Investments | $3,990,612,000 | $2,151,647,000 | $2,560,148,000 | $2,955,882,000 |
| Cash And Cash Equivalents | $2,774,151,000 | $1,527,186,000 | $1,870,315,000 | $1,558,595,000 |
| Debt | ||||
| Total Debt | $430,095,000 | $299,555,000 | $298,777,000 | $297,999,000 |
| Long Term Debt And Capital Lease Obligation | $430,095,000 | $299,555,000 | $298,777,000 | $297,999,000 |
| Long Term Debt | $430,095,000 | $299,555,000 | $298,777,000 | $297,999,000 |
| Liabilities | ||||
| Total Liabilities Net Minority Interest | $5,344,676,000 | $3,824,071,000 | $2,795,363,000 | $3,634,201,000 |
| Payables And Accrued Expenses | $4,046,664,000 | $2,956,417,000 | $2,083,951,000 | $2,882,869,000 |
| Payables | $4,046,664,000 | $2,956,417,000 | $2,083,951,000 | $2,882,869,000 |
| Other Payable | $2,587,700,000 | $1,558,341,000 | $1,056,941,000 | $1,517,493,000 |
| Accounts Payable | $1,458,964,000 | $1,398,076,000 | $1,027,010,000 | $1,365,376,000 |
| Derivative Product Liabilities | - | - | - | - |
| Equity | ||||
| Common Stock Equity | $977,648,000 | $1,013,586,000 | $803,967,000 | $890,384,000 |
| Total Equity Gross Minority Interest | $980,735,000 | $1,016,425,000 | $806,117,000 | $892,400,000 |
| Stockholders Equity | $977,648,000 | $1,013,586,000 | $803,967,000 | $890,384,000 |
| Gains Losses Not Affecting Retained Earnings | $18,030,000 | $-1,827,000 | $1,309,000 | $-9,715,000 |
| Other Equity Adjustments | $18,030,000 | $-1,827,000 | $1,309,000 | $-9,715,000 |
| Retained Earnings | $-3,294,434,000 | $-2,851,283,000 | $-2,876,715,000 | $-2,605,987,000 |
| Preferred Securities Outside Stock Equity | - | - | - | - |
| Other | ||||
| Treasury Shares Number | $315,000 | $315,000 | $314,600 | $314,600 |
| Ordinary Shares Number | $297,689,000 | $250,488,201 | $229,389,044 | $216,292,046 |
| Share Issued | $298,004,000 | $250,803,201 | $229,703,644 | $216,606,646 |
| Tangible Book Value | $977,648,000 | $1,013,586,000 | $803,967,000 | $890,384,000 |
| Invested Capital | $1,407,743,000 | $1,313,141,000 | $1,102,744,000 | $1,188,383,000 |
| Total Capitalization | $1,407,743,000 | $1,313,141,000 | $1,102,744,000 | $1,188,383,000 |
| Minority Interest | $3,087,000 | $2,839,000 | $2,150,000 | $2,016,000 |
| Treasury Stock | $2,923,000 | $2,923,000 | $2,923,000 | $2,923,000 |
| Additional Paid In Capital | $4,256,972,000 | $3,869,617,000 | $3,682,294,000 | $3,509,007,000 |
| Capital Stock | $3,000 | $2,000 | $2,000 | $2,000 |
| Common Stock | $3,000 | $2,000 | $2,000 | $2,000 |
| Investments And Advances | $1,216,461,000 | $624,461,000 | $689,833,000 | $1,397,287,000 |
| Net PPE | $88,350,000 | $66,793,000 | $61,930,000 | $59,888,000 |
| Other Short Term Investments | $1,216,461,000 | $624,461,000 | $689,833,000 | $1,397,287,000 |
| Preferred Stock | - | - | - | $0 |
Fetched: 2026-06-22
Cash Flow Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Free Cash Flow | ||||
| Free Cash Flow | $1,058,482,000 | $950,296,000 | $-297,736,000 | $351,337,000 |
| Operating Activities | ||||
| Operating Cash Flow | $1,094,854,000 | $978,193,000 | $-272,159,000 | $380,349,000 |
| Cash Flow From Continuing Operating Activities | $1,094,854,000 | $978,193,000 | $-272,159,000 | $380,349,000 |
| Operating Gains Losses | $-1,339,000 | $-23,000 | $70,000 | $1,274,000 |
| Investing Activities | ||||
| Capital Expenditure | $-36,372,000 | $-27,897,000 | $-25,577,000 | $-29,012,000 |
| Investing Cash Flow | $-241,060,000 | $-1,387,434,000 | $577,187,000 | $-226,519,000 |
| Cash Flow From Continuing Investing Activities | $-241,060,000 | $-1,387,434,000 | $577,187,000 | $-226,519,000 |
| Net Other Investing Changes | $4,275,000 | $3,929,000 | $-2,277,000 | $1,116,000 |
| Financing Activities | ||||
| Financing Cash Flow | $399,211,000 | $68,388,000 | $6,446,000 | $301,110,000 |
| Cash Flow From Continuing Financing Activities | $399,211,000 | $68,388,000 | $6,446,000 | $301,110,000 |
| Net Other Financing Charges | $-65,822,000 | - | $2,490,000 | $-5,189,000 |
| Issuance Of Capital Stock | - | - | $0 | $0 |
| Net Common Stock Issuance | - | - | $0 | $0 |
| Common Stock Issuance | - | - | $0 | $0 |
| Net Preferred Stock Issuance | - | - | - | $0 |
| Preferred Stock Issuance | - | - | - | $0 |
| Repurchase Of Capital Stock | - | - | - | - |
| Other | ||||
| Issuance Of Debt | $410,000,000 | $0 | $0 | $305,000,000 |
| Interest Paid Supplemental Data | $12,783,000 | $33,691,000 | $23,156,000 | $10,079,000 |
| Income Tax Paid Supplemental Data | $17,516,000 | $674,000 | $2,414,000 | $1,893,000 |
| End Cash Position | $2,804,123,000 | $1,551,118,000 | $1,891,971,000 | $1,580,497,000 |
| Beginning Cash Position | $1,551,118,000 | $1,891,971,000 | $1,580,497,000 | $1,125,557,000 |
| Changes In Cash | $1,253,005,000 | $-340,853,000 | $311,474,000 | $454,940,000 |
| Proceeds From Stock Option Exercised | $55,033,000 | $68,388,000 | $3,956,000 | $1,299,000 |
| Net Issuance Payments Of Debt | $410,000,000 | $0 | $0 | $305,000,000 |
| Net Long Term Debt Issuance | $410,000,000 | - | - | $305,000,000 |
| Long Term Debt Issuance | $410,000,000 | $0 | $0 | $305,000,000 |
| Net Investment Purchase And Sale | $-208,963,000 | $-1,363,466,000 | $605,041,000 | $-198,623,000 |
| Sale Of Investment | $804,955,000 | $770,044,000 | $1,442,023,000 | $994,083,000 |
| Purchase Of Investment | $-1,013,918,000 | $-2,133,510,000 | $-836,982,000 | $-1,192,706,000 |
| Net PPE Purchase And Sale | $-36,372,000 | $-27,897,000 | $-25,577,000 | $-29,012,000 |
| Purchase Of PPE | $-36,372,000 | $-27,897,000 | $-25,577,000 | $-29,012,000 |
| Change In Working Capital | $1,459,002,000 | $838,863,000 | $-192,086,000 | $854,999,000 |
| Change In Other Current Assets | $-27,116,000 | $-11,547,000 | $11,307,000 | $-243,000 |
| Change In Payables And Accrued Expense | $1,197,080,000 | $634,490,000 | $-856,358,000 | $1,003,324,000 |
| Change In Payable | $1,197,080,000 | $634,490,000 | $-856,358,000 | $1,003,324,000 |
| Change In Account Payable | $167,721,000 | $133,090,000 | $-395,806,000 | $280,229,000 |
| Change In Receivables | $98,569,000 | $-177,520,000 | $636,225,000 | $-551,148,000 |
| Changes In Account Receivables | $89,855,000 | $-164,666,000 | $638,288,000 | $-541,946,000 |
| Other Non Cash Items | $-10,738,000 | $-300,000 | $28,612,000 | $2,988,000 |
| Stock Based Compensation | $87,654,000 | $109,824,000 | $159,683,000 | $112,329,000 |
| Amortization Of Securities | $-29,793,000 | $-26,877,000 | $-29,374,000 | $2,480,000 |
| Deferred Tax | $2,449,000 | $-2,338,000 | $58,000 | $-165,000 |
| Deferred Income Tax | $2,449,000 | $-2,338,000 | $58,000 | $-165,000 |
| Depreciation And Amortization | $28,892,000 | $32,145,000 | $30,694,000 | $15,283,000 |
| Gain Loss On Investment Securities | $-1,339,000 | $-23,000 | $70,000 | $1,274,000 |
| Net Income From Continuing Operations | $-442,903,000 | $26,121,000 | $-270,594,000 | $-609,552,000 |
| Repayment Of Debt | - | - | $0 | $0 |
| Long Term Debt Payments | - | - | $0 | $0 |
| Common Stock Payments | - | - | - | - |
Fetched: 2026-06-22